DI NISIO, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 4.585
EU - Europa 3.237
AS - Asia 1.330
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 8
SA - Sud America 5
Totale 9.187
Nazione #
US - Stati Uniti d'America 4.569
IE - Irlanda 789
CN - Cina 743
UA - Ucraina 636
SE - Svezia 538
TR - Turchia 427
IT - Italia 401
GB - Regno Unito 272
DE - Germania 203
FR - Francia 160
FI - Finlandia 138
IN - India 64
VN - Vietnam 31
BE - Belgio 25
NL - Olanda 20
AT - Austria 17
TW - Taiwan 17
ES - Italia 14
CA - Canada 13
EU - Europa 12
AU - Australia 9
IR - Iran 7
HK - Hong Kong 6
TH - Thailandia 6
ID - Indonesia 5
IL - Israele 5
KR - Corea 5
RU - Federazione Russa 5
JP - Giappone 4
HR - Croazia 3
KE - Kenya 3
NO - Norvegia 3
SG - Singapore 3
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
MA - Marocco 2
MY - Malesia 2
SR - Suriname 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BR - Brasile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 9.187
Città #
Chandler 1.012
Jacksonville 891
Dublin 778
Princeton 403
Izmir 284
Nanjing 226
Ashburn 224
Southend 191
Altamura 187
Wilmington 174
Cambridge 142
Dearborn 136
Beijing 123
Boardman 89
Ann Arbor 84
Nanchang 73
Woodbridge 69
Chieti 63
Houston 58
Hebei 46
Kunming 45
Tianjin 38
Shenyang 36
Washington 36
Jiaxing 35
Helsinki 33
Dong Ket 31
Los Angeles 31
Seattle 29
Changsha 24
Brussels 23
Norwalk 22
New York 21
Hangzhou 17
Vienna 17
Fairfield 14
Falls Church 13
Leawood 13
Pune 13
Grevenbroich 12
Guangzhou 10
Hefei 10
Edinburgh 9
San Mateo 9
Changchun 8
Jinan 8
Madrid 8
Ardabil 7
Hanover 7
Orange 7
Sydney 7
Taipei 7
Amsterdam 6
Augusta 6
Bangkok 6
Mountain View 6
Suresnes 6
Teramo 6
Cheyenne 5
Redwood City 5
Rochester 5
Rome 5
Saint Louis 5
Auburn Hills 4
Des Moines 4
Florence 4
Hong Kong 4
Lanzhou 4
Monmouth Junction 4
New Taipei 4
Ningbo 4
Pescara 4
Plymouth 4
San Antonio 4
Seveso 4
Shanghai 4
Stockholm 4
Tappahannock 4
Vasto 4
Zhengzhou 4
Alba Adriatica 3
Andover 3
Frankfurt am Main 3
Gangbuk-gu 3
Haikou 3
Kocaeli 3
London 3
Marseille 3
Mcallen 3
Montenero Di Bisaccia 3
Montesilvano Marina 3
Montreal 3
Nairobi 3
Norfolk 3
Oslo 3
Oxford 3
Paris 3
Winchester 3
Alba 2
Asyut 2
Totale 6.040
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 187
Supportive management strategies for disseminated intravascular coagulation: An international consensus 124
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 108
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy 95
Treatment of Lower Extremity Superficial Thrombophlebitis 92
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 85
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 83
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 78
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 76
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 73
The hematocrit and platelet target in polycytemia vera 72
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 71
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 71
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 70
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 70
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 69
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 68
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 68
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 68
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 68
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 66
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 65
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 65
Rivaroxaban for cancer-associated cardiac thrombosis 65
Improving the diagnostic management of upper extremity deep vein thrombosis 65
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 64
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 64
Antithrombotic therapy and cancer 64
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 64
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 63
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 63
Circulating leptin is associated with oxidized LDL in postmenopausal women. 63
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 63
D-Dimer test in cancer patients with suspected acute pulmonary embolism 63
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 62
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 62
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 62
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 61
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 61
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 61
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 60
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 60
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 59
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 59
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 59
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 59
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 59
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 58
The SISET incorrectly cited the JAAM DIC scoring system 58
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 58
Cannabinoids for medical use: A systematic review and meta-analysis 58
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 58
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 58
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 57
Treatment for superficial infusion thrombophlebitis of the upper extremity. 57
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 57
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 57
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 57
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 56
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 56
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 56
Non-O blood group and outcomes of in vitro fertilization 56
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. 55
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 55
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 55
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 55
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 55
Cell-derived microvesicles and cancer 54
Decision analysis for cancer screening in idiopathic venous thromboembolism 54
Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 54
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: A systematic review 54
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 54
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 54
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 54
Pravastatin-dependent TGF-β1 effect on scavenger receptor class A expression in THP-1 human macrophages 54
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 54
Low molecular-weight heparins improve the survival of cancer patients? 53
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer 53
Deep vein thrombosis and pulmonary embolism 53
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 53
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 53
Splanchnic vein thrombosis: Current perspectives 53
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 53
Transforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 52
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 52
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 52
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 52
Edoxaban for the treatment of cancer-associated venous thromboembolism 52
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 52
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 52
Treatment for superficial thrombophlebitis of the leg 51
Direct Thrombin Inhibitors 51
Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? 51
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 51
Prevention of venous thromboembolism in hospitalized medical cancer patients: Guidance from the SSC of the ISTH 51
Cancer-associated unsuspected pulmonary embolism 51
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 51
Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. 6th International Symposium on global risk of coronary heart disease and stroke: assessment, prevention, and stroke 50
Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists 50
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment 50
Totale 6.237
Categoria #
all - tutte 39.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019342 0 0 0 0 0 0 0 0 0 0 14 328
2019/20201.913 626 127 49 24 175 89 248 143 43 164 203 22
2020/20211.008 132 22 283 27 76 233 10 9 14 73 50 79
2021/2022791 10 11 12 125 39 27 33 68 54 22 112 278
2022/20232.998 254 394 136 310 331 598 161 228 385 43 95 63
2023/20241.195 100 45 141 48 106 382 257 49 27 39 1 0
Totale 9.916